![](\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/94\/94000\/kblb_6m_450x350.png\")
The stock of Kraig Biocraft Laboratories Inc (OTCMKTS:KBLB<\/a>) was moving sideways above the 2 cent per share mark for quite some time during the first half of this year. After a decline in May we saw the ticker recover some of the lost value and become a bit more stable in June.<\/p>\n<\/p>\n
The company stock kept a decent market capitalization, which might have even been bigger than it was able to support. After all, the numbers of prime interest contained in KBLB<\/a>’s<\/strong> report for the first quarter of this year were the following.<\/p>\n <\/p>\n <\/p>\n Those numbers aren’t particularly great, but they are certainly not the only flag surrounding the company stock. Let’s not forget that, as we mentioned in our previous articles, KBLB<\/a><\/strong> has issued about 18 million shares at a price of $0.018 per share for a total of $300 thousand in proceeds since the beginning of this year.<\/p>\n <\/p>\n There is also the matter of the 9.5 million shares that came to existence as cashless exercises of warrants. This is why the latest downward run that KBLB<\/a><\/strong> has suffered through comes as no surprise. Yesterday we saw the ticker drop another 10.24% in value and close at $0.029619 per share.<\/p>\n <\/p>\n\n